How GenomiQa Hopes To Power Improved Outcomes In Cancer
Executive Summary
Colin Albert, CEO of genomiQa, outlines the potential and benefits of whole genome analysis in cancer therapy and research. Expansion plans into China and a collaborative ‘Immunotherapy Outcomes Project’ are some of the other key initiatives underway at the Australian genomic analytics company.